Corporates - Respiratory Diseases

A total of 1,525 corporates are partnering with Digital Health ventures that are operating within the Respiratory Diseases therapeutic area.

These stakeholders have closed a total of 2,026 partnerships. Their partner Digital Health ventures have an average maturity score of 417.3. Companies within this space partner primarily with ventures within the Medical Diagnostics Digital Health cluster.

Last Updated: August 22, 2026

Corporates

Result: 1524

Corporate Name	Number of Partners	Partners
AstraZeneca	39	Genetron Health (泛生子), Helix, asddswdsfd , asddswdsfd View All
Roche	25	Genetron Health (泛生子), Biodesix, asddswdsfd , asddswdsfd View All
Novartis	18	Genetron Health (泛生子), Koneksa, asddswdsfd , asddswdsfd View All
Pfizer	16	Epic Sciences, AbCellera, asddswdsfd , asddswdsfd View All
GSK	14	Helix, Ali Health (阿里健康), asddswdsfd , asddswdsfd View All
Microsoft	13	Preferred Networks (Preferred Networks), Lunit (루닛), asddswdsfd , asddswdsfd View All
Bayer	12	Genetron Health (泛生子), Burning Rock Biotech (燃石医学), asddswdsfd , asddswdsfd View All
MSD	11	Lunit (루닛), AbCellera, asddswdsfd , asddswdsfd View All
Takeda	10	Koneksa, Dawn Health, asddswdsfd , asddswdsfd View All
Philips	10	Biodesix, 4DMedical, asddswdsfd , asddswdsfd View All

Showing 1 to 10 of 1524 entries